George Sich
Foot Surgery · Aiken, SCNPI 1093804817
Payments from drug & device makers
What this record shows
Treace Medical Concepts, Inc. accounts for 73.9% of it on its own, with 21 other manufacturers making up the rest.
Across 69 payments — averaging $81.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$4K
- Bioventus LLC$434
- Team 1, LLC$176
- Bone Support Inc.$136
- Smith+Nephew$112
- Organogenesis Inc.$96
- plus $525 from 16 others
What the payments were for
- Travel & lodging$3,09755%
- Food & beverage$2,55645%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 24 | $4,175 |
| Bioventus LLC | 8 | $434 |
| Team 1, LLC | 2 | $176 |
| Bone Support Inc. | 1 | $136 |
| Smith+Nephew | 1 | $112 |
| Organogenesis Inc. | 4 | $96 |
| Amgen | 3 | $77 |
| Stryker | 3 | $72 |
| Melinta Therapeutics, LLC | 4 | $71 |
| Advanced Oxygen Therapy Inc. | 5 | $40 |
| Aap Implants Inc | 1 | $38 |
| Acera Surgical, Inc. | 2 | $34 |
| Abbott | 2 | $30 |
| Arthrosurface Incorporated | 1 | $27 |
| Averitas Pharma Inc. | 1 | $26 |
| ERMI LLC | 1 | $23 |
| Hydrofera LLC | 1 | $19 |
| Biotissue Holdings Inc. | 1 | $17 |
| Lemaitre Vascular, Inc. | 1 | $16 |
| AbbVie | 1 | $15 |
| Merck | 1 | $12 |
| Cashflow Solutions, LLC | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,653 in reported general payments places this provider in the 85th percentile of 28 foot surgery providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 76 | $1,908 |
| Ciclopirox | 11 | $298 |
| Silver Sulfadiazine | 22 | $144 |
| Allopurinol | 13 | $88 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Aiken
- Maureen QuinlanColumbia$46K
- Jordanna BakerFlorence$36K
- Christopher CrabtreeRock Hill$11K
- Amanda WarnerColumbia$9K
- Jeffrey ArmstrongCharleston$4K
- Heather DriessenColumbia$3K
- David NegronSpartanburg$2K
- James RoseAnderson$2K
- Brian RalphCharleston$1K
- Joseph MoranColumbia$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.